TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target

Pulmonary fibrosis (PF) is a chronic, progressive, fatal interstitial lung disease with limited available therapeutic strategies. We recently reported that the protein kinase glycogen synthase kinase-3β (GSK-3β) interacts with and inactivates the ubiquitin-editing enzyme A20 to suppress the degradat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shanshan, Lv, Xiaoxi, Wei, Xupeng, Liu, Chang, Li, Qiao, Min, Jiali, Hua, Fang, Zhang, Xiaowei, Li, Ke, Li, Pingping, Xiao, Yang, Hu, Zhuowei, Cui, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546892/
https://www.ncbi.nlm.nih.gov/pubmed/34729304
http://dx.doi.org/10.1016/j.apsb.2021.06.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546892/
https://www.ncbi.nlm.nih.gov/pubmed/34729304
http://dx.doi.org/10.1016/j.apsb.2021.06.017

Ejemplares similares